Incyte to Present at Upcoming Investor Conferences
- Goldman Sachs Twenty-Eighth Annual Global Healthcare Conference on Tuesday, June 12, 2007 at 4:00 p.m. (PT) / 7:00 p.m. (ET) in Dana Point, California;
- Piper Jaffray Second Annual London Health Care Conference on Thursday, June 21, 2007 at 8:20 a.m. (BST) in London; and
- Jefferies Healthcare Conference on Wednesday, June 27, 2007 at 1:30 p.m. (ET) in New York.
The presentations will be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts. A replay of the presentations will be available. Investors interested in listening to the live webcast should log on before the start time in order to download any software required.
Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs. Incyte has a pipeline with programs in HIV, diabetes, oncology and inflammation. For additional information on Incyte visit the Company's web site at www.incyte.com.
CONTACT: Incyte Corporation
Pamela M. Murphy
Vice President, Investor Relations/Corporate
Communications
302-498-6944
SOURCE: Incyte Corporation